Literature DB >> 7850840

Polymeric endoluminal paving. A family of evolving methods for extending endoluminal therapeutics beyond stenting.

M J Slepian1.   

Abstract

This article briefly reviews the background and rationale for the development of polymer paving. The process of endoluminal paving is described both in its generic form as well as in three experimental embodiments. Several experimental studies with two forms of paving, solid paving and gel paving, are reviewed. Finally, the envisioned future clinical role for both solid and gel paving is described.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7850840

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  5 in total

1.  Physical Characterization and Platelet Interactions under Shear Flows of a Novel Thermoset Polyisobutylene-based Co-polymer.

Authors:  Jawaad Sheriff; Thomas E Claiborne; Phat L Tran; Roshni Kothadia; Sheela George; Yasushi P Kato; Leonard Pinchuk; Marvin J Slepian; Danny Bluestein
Journal:  ACS Appl Mater Interfaces       Date:  2015-09-23       Impact factor: 9.229

2.  The Influence of Polymer Processing Methods on Polymer Film Physical Properties and Vascular Cell Responsiveness.

Authors:  Kaitlyn R Ammann; Maxwell Li; Syed Hossainy; Marvin J Slepian
Journal:  ACS Appl Bio Mater       Date:  2019-05-02

3.  Polymeric endoaortic paving: Mechanical, thermoforming, and degradation properties of polycaprolactone/polyurethane blends for cardiovascular applications.

Authors:  J H Ashton; J A M Mertz; J L Harper; M J Slepian; J L Mills; D V McGrath; J P Vande Geest
Journal:  Acta Biomater       Date:  2010-09-09       Impact factor: 8.947

4.  MMP-sensitive PEG hydrogel modified with RGD promotes bFGF, VEGF and EPC-mediated angiogenesis.

Authors:  Liu Ouyang; Yang Dan; Zengwu Shao; Shuhua Yang; Cao Yang; Guohui Liu; Deyu Duan
Journal:  Exp Ther Med       Date:  2019-08-13       Impact factor: 2.447

Review 5.  Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention.

Authors:  Rebecca A Scott; Alyssa Panitch
Journal:  Biomacromolecules       Date:  2014-07-08       Impact factor: 6.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.